{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04977",
    "Peptide Name": "RL-30 (Gj-CATH2 N-terminal fragment, RA-48 fragment, Lys-rich, synthetic AMPs, UCLL1)",
    "Source": "sequence truncation, reptiles, animal-derived, natural derivatives",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "RRGIKKFIKKVKKVKKAIKEGIKKGIKKLL",
    "Sequence Length": 30,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 14,
    "Boman Index": 1.95,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "37%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (62.5%) toGj-CATH2K: 43%, I: 17%.Activity: active against S. aureus ATCC6538 (MIC 9.37 ug/ml) and A. baumannii ATCC19606 (MIC 18.75 ug/ml).SAR: this N-terminal fragment has similar activity to WT cathelicidin, while the rest C-terminal sequence is inactive against these two bacteria.",
    "Author": "Wu Z, Cai Y, Han Y, Su Y, Zhang T, Wang X, Yan A, Wang L, Wu S, Wang G, Zhang Z. 2024",
    "Reference": "J Med Chem. 2024 Nov 1. doi: 10.1021/acs.jmedchem.4c01855.PubMed",
    "Title": "Development of alpha-Helical Antimicrobial Peptides with Imperfect Amphipathicity for Superior Activity and Selectivity."
  },
  "3D Structure": []
}